Kubota Vision
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Kubota Vision sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Kubota Vision: 16 sponsored US clinical trials, none currently recruiting.
Kubota Vision sponsors 16 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 16 completed. 2 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Keratoconjunctivitis Sicca, with 1 trials.
Top-decile sponsor footprint
Kubota Vision ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
16 total, page 1 of 1
Kubota Glass Parameter Refinement Study
NCT06085430
Projected Peripheral Defocus Using a Wearable Device
NCT04415684
Effects of Projected Peripheral Defocus on Ocular Biometrics
NCT04388020
Study Evaluating Retinal Health Monitoring System Visual Acuity Module.
NCT04169802
Safety and Efficacy of Emixustat in Stargardt Disease
NCT03772665
Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
NCT03033108
Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
NCT02753400
Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
NCT02130531
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
NCT01802866
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
NCT01632137
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
NCT01410188
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
NCT01057147
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
NCT01027013
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
NCT01002950
Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects
NCT00942240
Safety and Tolerability of ACU-4429
NCT00703183
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 3 | 2 |
Therapeutic Areas
How the Kubota Vision early-phase archive is shaped
16 indexed studies, none listed as recruiting (0% open); 16 completed (100%).
Phase mix: 2 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Keratoconjunctivitis Sicca (1 trial), 6 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Kubota Vision: archived-pipeline peers nationwide
Peers matched on 16 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Kubota Vision sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 archived trials
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Kubota Vision page
16 registered trials is a research-attention snapshot, not an endorsement of Kubota Vision or any single study.
- None of Kubota Vision's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Keratoconjunctivitis Sicca is the condition Kubota Vision studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Keratoconjunctivitis Sicca trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kubota Vision pipeline card: 16 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.